Emerging Evidence for Cardiorenal Protection with Sodium-Glucose Cotransporter Inhibitors, Glucagon-like peptide-1 Receptor Agonists, and Mineralocorticoid Receptor Blockers in People with Type 1 Diabetes.
来源：PubMed发布日期：2026-09-01作者：Fernandes S, Hettinger B, Ang L, Pop-Busui R0 次点击